Progress is our Promise: 2017 in Review

A year ago, Faith couldn’t lift her arms above her head.

Today, she can.

Progress is our promise.

In 2017, MDA helped thousands of families live better and longer lives.

The FDA approved Emflaza, another drug to treat muscular dystrophy this year.

In the past 24 months, four drugs — including Exondys 51, Spinraza, Keveyis and Emflaza —  have become available thanks to support from MDA.

To keep the momentum going, we awarded $18.2 million in new research grants in 2017.

MDA Care Centers provided expert care for tens of thousands of individuals this year.

It’s one of the only places families can meet with many of their health care specialists at one time, in one place.

MDA was here for families when and where they needed us in 2017.

Trained MDA specialists answered your emails and phone calls with resources and a shoulder to lean on…20,000 times.

Thousands of kids gained independence, self-confidence, and important life skills at MDA Summer Camp.

They told us it’s the best week of the year.

All of this and much more was possible thanks to you.

Thank you for helping MDA make 2017 a remarkable year for the families we serve.

Until Dec. 31, 2017 your support can mean twice as much — an anonymous group of generous donors has agreed to match every donation made, dollar for dollar, up to $100,000. Thanks in advance for your contributions.

Donate Today